REFERENCES
- Polevoda B, Sherman F. N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J Mol Biol 2003; 325(4)595–622
- Vasseur C, Blouquit Y, Kister J, Prome D, Kavanaugh JS, Rogers PH, Guillemin C, Arnone A, Galacteros F, Poyart C, Rosa J, Wajcman H. Hemoglobin Thionville. An α-chain variant with a substitution of a glutamate for valine at NA-1 and having an acetylated methionine NH2 terminus. J Biol Chem 1992; 267(18)12682–12691
- Kamel K, El-Najjar A, Webber BB, Chen SS, Wilson JB, Kutlar A, Huisman THJ. Hb Doha or α2β2[X-N-Met-1(NA1)Val→Glu]; a new β chain abnormal hemoglobin observed in a Qatari female. Biochim Biophys Acta 1985; 831(2)257–260
- Boissel JP, Kasper TJ, Shah SC, Malone JI, Bunn HF. Amino-terminal processing of proteins: Hemoglobin South Florida, a variant with retention of initiator methionine and N α-acetylation. Proc Natl Acad Sci USA 1985; 82(24)8448–8452
- Harteveld CL, Versteegh FGA, van Leer EHG, Starreveld JS, Kok PJMJ, van Roijen-Nijdam I, van Delft P, Zanella-Cleon I, Becchi M, Wajcman H, Giordano PC. Hb St. Jozef, a Val→Leu N-terminal mutation leading to retention of the methionine, and partial acetylation found in the globin gene in cis with a –α3.7thalassemia deletion. Hemoglobin 2007; 31(3)313–323
- Ohba Y, Hattori Y, Sakata S, Yamashiro Y, Okayama N, Hirano T, Nakanishi T, Miyazaki A, Shimizu A. Hb Niigata [β1(NA1)Val→Leu]: the fifth variant with retention of the initiator methionine and partial acetylation. Hemoglobin 1997; 21(2)179–186
- Watanabe T, Kato K, Yamada D, Midorikawa S, Sato W, Shiga M, Otsuka Y, Miura M, Harano K, Harano T. A nondiabetic case of hemoglobin variant (Hb Niigata) with inappropriately high and low HbA1c titers detected by different methods. Clin Chem 1998; 44(7)1562–1564
- Blouquit Y, Arous N, Lena D, Delanoe-Garin J, Lacombe C, Bardakdjian J, Vovan L, Orsini A, Rosa J, Galacteros F. Hb Marseille [α2β2N methionyl-2 (NA2) His→Pro]: a new β chain variant having an extended N-terminus. FEBS Lett 1984; 178(2)315–318
- Prchal JT, Cashman DP, Kan YW. Hemoglobin Long Island is caused by a single mutation (adenine to cytosine) resulting in a failure to cleave amino-terminal methionine. Proc Natl Acad Sci USA 1986; 83(1)24–27
- http://globin.cse.psu.edu, Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagnou N, Miller W, Wajcman H. HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 2002; 19(3):225–233
- Patrinos GP, Giardine B, Riemer C, Miller W, Chui DHK, Anagnou NP, Wajcman H, Hardison RC. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 2004; 32(Database issue)D537–D541
- Harano T, Harano K, Kushida Y, Imai K, Nishinakamura R, Matsunaga T. Hb Kodaira [β146(HC3)His→Gln]: a new β chain variant with an amino acid substitution at the C-terminus. Hemoglobin 1992; 16(1&2)85–91
- So CC, Ma SK, Law KM, Chan AY, Chan LC, Wong KF. Hb Kodaira II: a high oxygen affinity variant with a novel mutation in the β-globin gene and phenotypic identity to Hb Kodaira. Hemoglobin 2002; 26(2)205–207
- Kazazian HH, Jr, Orkin SH, Antonarakis SE, Sexton JP, Boehm CD, Goff SC, Waber PG. Molecular characterization of seven β-thalassemia mutations in Asian Indians. EMBO J 1984; 3(3)593–596
- Ribeiro MLS, Baysal E, Kutlar F, Tamagnini GP, Goncalves P, Lopes D, Huisman THJ. A novel β0-thalassaemia mutation (codon 15, TGG→TGA) is prevalent in a population of central Portugal. Br J Haematol 1992; 80(4)567–568
- den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15(1)7–12